Anti-Asthma / COPD
Anti-Cancer / Oncology
Antiretroviral / Anti-HIV
Erectile Dysfunction (ED)
Monoclonal Antibodies (mAbs)
Research & Development (Preclinical Lab APIs)
Clinical Phase API Supplies
Commercial Stage cGMP APIs
APIs for Drug Delivery Systems
Regulatory Support Services
Contract Research & Manufacturing Services
Press & Media
Trade Shows & Events
Search products by name or CAS#
Featured Needs Work
LGM Pharma is a Trelagliptin Succinate CAS# 1029877-94-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
Questions? Call our customer API support number 1-(800)-881-8210.
LGM Pharma offers this active ingredient but not the finished dosage forms.
Butanedioic acid, compd. with 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-4-fluorobenzonitrile (1:1), SYR 111472 succinate, SYR 472, Syr-472, Syr111472 succinate, Trelagliptin succinate, UNII-4118932Z90
Typically NLT 98%
2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2, 4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile; butanedioic acid
Mode of Action:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
API’s From Quality Manufacturers:
Cost effective materials based on specific requirements
Small quantities for initial research and larger development quantities towards product commercialization
Technical packages, letters of access to filed DMFs
Complete assistance in any regulatory filings
Top quality GMP certified manufacturers
Have necessary regulatory credentials
Related YouTube Videos